Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Soligenix, Inc.
Unilever names Schumacher as Jope’s successor at CEO; specialty aerosol, liquid products firm PLZ appoints CEO; GOED seats 2023 board officers; and CRN adds and promotes staff members.
Keeping Track: US FDA Oncology Approvals For Ferring’s Gene Therapy Adstiladrin And Mirati’s Targeted Therapy Krazati
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker
FTC asks for comments on whether it should consider issuing guidance on “organic” and “sustainable” claims in an update to its Green Guides. Commission will collect public comments for 60 days beginning mid-January for first update to guides in 10 years.
Plus deals involving Dong-A/Polifarma, Intas/Syna, Kissei/Synmosa, Ono/Memo, Takeda/Shionogi, Fosun/Lilly and JW Therapeutics/2seventy bio.
- Drug Delivery
- Large Molecule
- Other Names / Subsidiaries
- Biological Therapeutics, Inc.
- DOR BioPharma, Inc.
- Endorex Corporation
- Enteron Pharmaceuticals
- Immunotherapeutics Inc.
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.